Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026
NCNO vs GDRX: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
GDRX Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 4–5 Matrix Metrics)
GDRX Overall Winner
6-Pillar Tally: NCNO 2 – 4 GDRX
Matrix Metrics: NCNO 5 – 4 GDRX
As of Nov 17, 2026, GoodRx Holdings, Inc. (GDRX) is the stronger overall head-to-head candidate over nCino, Inc. (NCNO) in the Tradestie Institutional Equity Comparison Engine, winning 4–5 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Options & Positioning). NCNO carries a Unified Composite Score of 49.3/100 (HOLD) at $22.43 (22.2x Forward P/E, 8.2% operating margin), whereas GDRX carries 54.4/100 (HOLD) at $3.45 (10.0x Forward P/E, 11.4% operating margin).
- Technical & Structure Timing Caution: NCNO trades in a Markup technical trend (CONSOLIDATION options phase, RSI 53.2); meanwhile GDRX is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 47.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Executive Snapshot Side-by-Side Composite Ratings & Technical Regime
Ask Alpha AI About NCNO vs GDRX
NCNO
nCino, Inc. Common Stock
$22.43
-1.51% 1D
Market Cap
$2.4B
TTM Revenue
$622M
Forward P/E
22.2x
Beta / 30D Vol
0.40β · 38% Vol
Unified Composite Score
49.3
HOLD
Tech 38.0
Fund 53.0
Flow 67.0
Mom 60.0
Weinstein Technical Phase
Markup · Hold / add on dips
GDRX
Head-to-Head Winner
GoodRx Holdings, Inc. Class A Common Stock
$3.45
-1.71% 1D
Market Cap
$1.2B
TTM Revenue
$785M
Forward P/E
10.0x
Beta / 30D Vol
1.22β · 47% Vol
Unified Composite Score
54.4
HOLD
Tech 49.0
Fund 60.0
Flow 74.0
Mom 56.0
Weinstein Technical Phase
Distribution · Trim / tighten stop
6-Pillar Scorecard Institutional Category Breakdown (NCNO 2 – 4 GDRX)
1. Valuation Multiples
GDRX
Forward P/E
22.2x
10.0x
Trailing P/E
71.1x
71.2x
PEG Ratio
N/M
N/M
EV / Revenue
4.3x
1.9x
2. Growth & Scale
NCNO
Revenue Growth (YoY)
+8.2%
-1.3%
Earnings Growth (YoY)
+147.6%
-44.5%
TTM Revenue (USD)
$622M
$785M
Market Cap
$2.4B
$1.2B
3. Profitability & Quality
GDRX
Gross Margin
62.2%
90.8%
Operating Margin
8.2%
11.4%
Net Profit Margin
5.4%
2.1%
Return on Equity (ROE)
3.9%
2.5%
4. Balance Sheet & Cash Flow
NCNO
Cash Generation (TTM)
$132M
$132M
Cash Flow Margin
21.2%
16.8%
Net Cash / Leverage
$255M Net Debt (0.36x D/E)
$243M Net Debt (0.83x D/E)
Dividend Yield
None (0.00%)
None (0.00%)
5. Options & Positioning
GDRX
Options Structure Phase
CONSOLIDATION
BREAKOUT
Current IV / %ile
55.7% (20th %ile)
66.5% (16th %ile)
Put/Call OI Skew
0.02x (Call-Skewed)
N/A
OBV Trend / Tech Phase
DISTRIBUTION · Markup
NEUTRAL · Distribution
6. R&D & Supply-Chain Moat
GDRX
OpEx & R&D Intensity
54.0% of Rev ($336M)
79.4% of Rev ($623M)
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Cyclical / Execution-Driven Positioning
Cyclical / Execution-Driven Positioning
Supply-Chain Role
Software - Application Operator
Health Information Services Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: NCNO (5) vs GDRX (4)| Institutional Metric | NCNO | GDRX | Criterion | Row Edge |
|---|---|---|---|---|
| Market Capitalization | $2.4B | $1.2B | NCNO | |
| Trailing P/E Ratio | 71.1x | 71.2x | Tie | |
| Forward P/E Ratio | 22.2x | 10.0x | GDRX | |
| Revenue Growth (YoY) | +8.2% | -1.3% | NCNO | |
| Operating Margin (TTM) | 8.2% | 11.4% | GDRX | |
| Net Profit Margin | 5.4% | 2.1% | NCNO | |
| Return on Equity (ROE) | 3.9% | 2.5% | NCNO | |
| 52-Week Range Position | 63% ($14–$28) | 79% ($2–$4) | GDRX | |
| Beta / 30D Volatility | 0.40β · 38% Vol | 1.22β · 47% Vol | NCNO | |
| Unified Institutional Score | 49.3 / 100 (HOLD) | 54.4 / 100 (HOLD) | GDRX | |
| Trailing 12M Revenue (USD) | $622M | $785M | Scale | |
| Gross Profit Margin (TTM) | 62.2% | 90.8% | Quality | |
| PEG Ratio & EV / Revenue | N/M PEG · 4.3x EV/Rev | N/M PEG · 1.9x EV/Rev | Valuation | |
| Cash Flow & Balance Sheet | $132M ($255M Net Debt (0.36x D/E)) | $132M ($243M Net Debt (0.83x D/E)) | Solvency |
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M Horizon
NCNO +7.88 pp
3M Horizon
NCNO +10.97 pp
6M Horizon
NCNO +12.17 pp
1Y Horizon
GDRX +28.25 pp
Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | NCNO Revenue | GDRX Revenue | NCNO Op. Margin | GDRX Op. Margin | Margin Leader |
|---|---|---|---|---|---|
| FY2019 | N/A | $390M | N/A | 36.0% | GDRX |
| FY2020 | $140M | $550M | -20.4% | -50.1% | NCNO |
| FY2021 | $200M | $750M | -20.9% | 1.8% | GDRX |
| FY2022 | $270M | $770M | -26.1% | 0.2% | GDRX |
| FY2023 | $410M | $750M | -23.0% | -3.6% | GDRX |
| FY2024 | $480M | $790M | -8.3% | 8.3% | GDRX |
| FY2025 | $540M | $800M | -3.4% | 11.0% | GDRX |
| FY2026 | $590M | N/A | 0.6% | N/A | NCNO |
Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor
Live Options Phase Tracker
NCNO
CONSOLIDATION
Current IV
55.7%
IV Percentile
20th %ile
Put/Call OI Skew
0.02x (Call-Skewed)
IV Regime
Compressed (<25th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BULLISH
OBV Flow
DISTRIBUTION
Exact NCNO Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
GDRX
BREAKOUT
Current IV
66.5%
IV Percentile
16th %ile
Put/Call OI Skew
N/A
IV Regime
Compressed (<25th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BULLISH
OBV Flow
NEUTRAL
Exact GDRX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity
Corporate R&D & Foundry Leaderboard
NCNO Moat Profile
Cyclical / Execution-Driven Positioning
Software - Application Operator
OpEx & R&D Reinvestment
54.0% of Rev ($336M)
90D Engineering Disclosures
0 Published
GDRX Moat Profile
Cyclical / Execution-Driven Positioning
Health Information Services Operator
OpEx & R&D Reinvestment
79.4% of Rev ($623M)
90D Engineering Disclosures
0 Published
Investor FAQ NCNO vs GDRX Key Questions & Quantitative Answers
As of Nov 17, 2026, GoodRx Holdings, Inc. (GDRX) is the stronger overall head-to-head candidate over nCino, Inc. (NCNO) in the Tradestie Institutional Equity Comparison Engine, winning 4–5 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Options & Positioning). NCNO carries a Unified Composite Score of 49.3/100 (HOLD) at $22.43 (22.2x Forward P/E, 8.2% operating margin), whereas GDRX carries 54.4/100 (HOLD) at $3.45 (10.0x Forward P/E, 11.4% operating margin). Technical & Structure Timing Caution: NCNO trades in a Markup technical trend (CONSOLIDATION options phase, RSI 53.2); meanwhile GDRX is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 47.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
NCNO leads the Growth & Scale pillar: NCNO posts +8.2% YoY revenue growth and +147.6% YoY earnings growth on $622M TTM revenue (62.2% gross margin, 8.2% operating margin), compared with GDRX at -1.3% YoY revenue growth and -44.5% YoY earnings growth on $785M TTM revenue (90.8% gross margin, 11.4% operating margin). Across the 8-period historical trajectory (FY2019 to FY2026), NCNO cumulative revenue shifted +321.4% while GDRX shifted +105.1%. In operating R&D and SG&A reinvestment, NCNO deploys 54.0% of Rev ($336M) (0 90-day corporate R&D disclosures) versus 79.4% of Rev ($623M) (0 disclosures) for GDRX.
GDRX screens cheaper on headline valuation multiples. NCNO trades at 22.2x Forward P/E, 71.1x Trailing P/E, N/M PEG, and 4.3x EV/Revenue (21.2% FCF margin), whereas GDRX trades at 10.0x Forward P/E, 71.2x Trailing P/E, N/M PEG, and 1.9x EV/Revenue (16.8% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against NCNO (3.9% ROE) versus GDRX (2.5% ROE) capital efficiency.
In options market volatility and institutional positioning, NCNO carries 55.7% implied volatility (20th %ile, Compressed (<25th %ile)), a 0.02x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.40β · 38% Vol realized risk). By comparison, GDRX carries 66.5% implied volatility (16th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a BREAKOUT options structure phase (1.22β · 47% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Launch Custom Ticker Comparison →
GDRX vs NCNO · Reverse Pair
NCNO vs GTM
· Sector Peer
NCNO vs FROG
· Sector Peer
NCNO vs BILL
· Sector Peer
GDRX vs AMWL
· Sector Peer
GDRX vs FROG
· Sector Peer
INTC vs AMD
· x86 & Data Center CPU
NVDA vs AMD
· AI Accelerators
TSM vs ASML
· Foundry & Lithography
MSFT vs GOOGL
· Hyperscale Cloud & AI
AAPL vs META
· Consumer Ecosystem